CDC7 and ovarian carcinoma: This was shown by Li et al. in ovarian cancer models, where sequential administration of carboplatin and cell division cycle 7-related protein kinase (CDC7) inhibitor, XL413, showed synergistic enhancement of apoptosis [93].